GMED logo

Globus Medical (GMED)

Profile

Full Name

Globus Medical, Inc.

Ticker Symbol

GMED

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

August 3, 2012

Indexes

Not included

Website

http://www.globusmedical.com

Employees

5300

Key Details

Price

$72.35(-0.86%)

Market cap

$9.95B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.52B(+60.62% YoY)

Annual EPS

$0.75(-29.91% YoY)

PE ratio

96.47

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$72.35
GMED price is $72.35

30-Day Relative Volume

0.54
GMED 30-day relative volume is 0.54

Price Performance

Price Most recent change

-0.86%
GMED price was down -0.86% on Apr 15, 2025

Price YTD change

-12.53%
GMED price is down -12.53% since January 1st

Price 1-year change

+39.7%
GMED price is up +39.7% year-on-year

Price 3-year change

-6.65%
GMED price is down -6.65% over the past 3 years

Price Range

Price All-time high

$94.93
GMED price is currently -23.79% below its historical high of $94.93

Price 3-year low

$43.39
GMED price is currently +66.74% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$9.95B
GMED market capitalization is $9.95 billion

Market cap 3-year change

+26.22%
GMED market capitalization is up +26.22% over the past 3 years

Market cap All-time high

$12.92B
GMED market capitalization is currently -22.96% below its historical high of $12.92 billion

Market cap sector rank

92.6%
GMED market capitalization is higher than 92.6% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.84%
GMED shares outstanding is up +1.84% year-on-year

Shares Outstanding 3-Year Change

+35.2%
GMED shares outstanding is up +35.2% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.86
GMED beta is 0.86

200-day SMA

$76.92
GMED price is currently -5.94% below its 200-day simple moving average

50-day SMA

$77.40
GMED price is currently -6.52% below its 50-day simple moving average

RSI

46.63
GMED 14-day relative strength index is 46.63

Volume

0.54
GMED 30-day relative volume is 0.54

ATR

$3.16
GMED average true range is $3.16

10-day Historical Volatility

66.78%
GMED 10-day historical volatility is 66.78%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.52B
GMED annual revenue is $2.52 billion

Revenue Analysts estimate

$2.70B
GMED annual revenue is currently -6.55% lower than the consensus analysts' forecast

Revenue 1-year change

+60.62%
GMED annual revenue is up +60.62% year-on-year

Revenue Sector rank

86.7%
GMED annual revenue is higher than 86.7% of companies in Healthcare sector

EPS

EPS

$0.75
GMED annual earnings per share is $0.75

EPS Analysts estimate

$3.44
GMED annual earnings per share is currently -78.20% lower than the consensus analysts' forecast

EPS 1-year change

-29.91%
GMED annual earnings per share is down -29.91% year-on-year

EPS Sector rank

88.32%
GMED annual earnings per share is higher than 88.32% of companies in Healthcare sector

Profit

Gross profit

$1.48B
GMED annual gross profit is $1.48 billion

Gross margin

58.90%
GMED annual gross profit margin is 58.90%

Operating profit

$219.70M
GMED annual operating income is $219.70 million

Operating margin

8.72%
GMED annual operating profit margin is 8.72%

Net income

$102.98M
GMED annual net profit is $102.98 million

Net margin

4.09%
GMED annual net profit margin is 4.09%

Expenses

Total expenses

$2.30B
GMED annual total expenses is $2.30 billion

Operating expenses

$1.26B
GMED annual total operating expenses is $1.26 billion

Cost of goods sold

$1.04B
GMED annual cost of goods sold is $1.04 billion

Selling, general & administrative expenses

$981.05M
GMED annual SGA is $981.05 million

Depreciation and amortization

$254.02M
GMED annual depreciation & amortization is $254.02 million

Interest expense

-
GMED annual interest expense value is unknown

Income tax

$17.74M
GMED annual income tax is $17.74 million

EBIT & EBITDA

EBIT

$219.70M
GMED annual earnings before interest & taxes is $219.70 million

EBITDA

$473.73M
GMED annual EBITDA is $473.73 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$5.25B
GMED annual total assets is $5.25 billion

Non current assets

$3.07B
GMED annual long term assets is $3.07 billion

Current assets

$2.18B
GMED annual total current assets is $2.18 billion

Cash and cash equivalents

$784.44M
GMED annual cash & cash equivalents is $784.44 million

Accounts receivable

$557.70M
GMED annual accounts receivable is $557.70 million

Inventory

$659.23M
GMED annual inventory is $659.23 million

Liabilities

Total liabilities

$1.07B
GMED annual total liabilities is $1.07 billion

Long term liabilities

$218.50M
GMED annual total long term liabilities is $218.50 million

Current liabilities

$855.91M
GMED annual total current liabilities is $855.91 million

Accounts payable

$75.12M
GMED annual accounts payable is $75.12 million

Debt

Total debt

$537.19M
GMED annual total debt is $537.19 million

Total debt 1-year change

+3.23%
GMED annual total debt is up +3.23% year-on-year

Long term debt

$83.59M
GMED annual long term debt is $83.59 million

Short term debt

$453.60M
GMED annual short term debt is $453.60 million

Equity & Capital

Shareholders equity

$4.18B
GMED annual stockholders equity is $4.18 billion

Book value

$4.18B
GMED annual book value is $4.18 billion

Retained earnings

$1.15B
GMED annual retained earnings is $1.15 billion

Working capital

$1.32B
GMED annual working capital is $1.32 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$520.64M
GMED annual cash flow from operations is $520.64 million

Cash from operations 1-year change

+113.82%
GMED annual cash flow from operations is up +113.82% year-on-year

Cash from investing

-$176.05M
GMED annual cash flow from investing activities is -$176.05 million

Cash from investing 1-year change

-158.11%
GMED annual cash flow from investing activities is down -158.11% year-on-year

Cash from financing

-$27.70M
GMED annual cash flow from financing activities is -$27.70 million

Cash from financing 1-year change

+88.05%
GMED annual cash flow from financing activities is up +88.05% year-on-year

CAPEX

CAPEX

$115.43M
GMED annual capital expenditures is $115.43 million

CAPEX 1-year change

+47.47%
GMED annual capital expenditures is up +47.47% year-on-year

Free Cash Flow

Free cash flow

$405.21M
GMED annual free cash flow is $405.21 million

Free cash flow 1-year change

+145.25%
GMED annual free cash flow is up +145.25% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

58.90%
GMED annual gross profit margin is 58.90%

Operating margin

8.72%
GMED annual operating profit margin is 8.72%

Net margin

4.09%
GMED annual net profit margin is 4.09%

ROA & ROE

ROA

1.99%
GMED annual return on assets is 1.99%

ROE

2.52%
GMED annual return on equity is 2.52%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

96.47
GMED price to earnings ratio is 96.47

PE ratio Sector rank

91.18%
GMED price to earnings ratio is higher than 91.18% of companies in Healthcare sector

PB Ratio

PB ratio

2.38
GMED price to book ratio is 2.38

PB ratio Sector rank

67.57%
GMED price to book ratio is higher than 67.57% of companies in Healthcare sector

PS Ratio

PS ratio

3.95
GMED price to sales ratio is 3.95

PS ratio Sector rank

60.77%
GMED price to sales ratio is higher than 60.77% of companies in Healthcare sector

Enterprise value

Enterprise value

$9.70B
GMED enterprise value is $9.70 billion

Enterprise value Sector rank

91.81%
GMED enterprise value is higher than 91.81% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

20.48
GMED EV/EBITDA is 20.48

EV/EBITDA Sector rank

91.82%
GMED EV/EBITDA is higher than 91.82% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.54
GMED annual current ratio is 2.54

Quick ratio

1.77
GMED annual quick ratio is 1.77

Leverage

Debt to equity

0.11
GMED annual debt to equity ratio is 0.11

Interest coverage ratio

-
GMED annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

7
GMED piotroski f-score is 7

Altman Z-Score

6.78
GMED altman z-score is 6.78

Analyst ratings

Recent major analysts updates

Apr 11, 25 Truist Securities
Hold
Mar 18, 25 Truist Securities
Hold
Mar 18, 25 Needham
Hold
Feb 24, 25 Citizens Capital Markets
Market Perform
Feb 24, 25 Barclays
Overweight
Feb 21, 25 Wells Fargo
Overweight
Feb 21, 25 Stifel
Buy
Feb 21, 25 Needham
Hold
Feb 6, 25 Needham
Hold
Jan 10, 25 Canaccord Genuity
Buy

Institutional Ownership

Similar stocks

DOCS logo
Doximity (DOCS)
MRNA logo
Moderna (MRNA)
EXEL logo
Exelixis (EXEL)
EHC logo
Encompass Health (EHC)
NBIX logo
Neurocrine Biosciences (NBIX)
ATR logo
AptarGroup (ATR)
AVTR logo
Avantor (AVTR)
PEN logo
Penumbra (PEN)
WBA logo
Walgreens Boots Alliance (WBA)
  • What is the ticker symbol for Globus Medical?
  • Does Globus Medical pay dividends?
  • What sector is Globus Medical in?
  • What industry is Globus Medical in?
  • What country is Globus Medical based in?
  • When did Globus Medical go public?
  • Is Globus Medical in the S&P 500?
  • Is Globus Medical in the NASDAQ 100?
  • Is Globus Medical in the Dow Jones?
  • When was Globus Medical's last earnings report?
  • When does Globus Medical report earnings?
  • Should I buy Globus Medical stock now?

What is the ticker symbol for Globus Medical?

The ticker symbol for Globus Medical is NYSE:GMED

Does Globus Medical pay dividends?

No, Globus Medical does not pay dividends

What sector is Globus Medical in?

Globus Medical is in the Healthcare sector

What industry is Globus Medical in?

Globus Medical is in the Medical Devices industry

What country is Globus Medical based in?

Globus Medical is headquartered in United States

When did Globus Medical go public?

Globus Medical's initial public offering (IPO) was on August 3, 2012

Is Globus Medical in the S&P 500?

No, Globus Medical is not included in the S&P 500 index

Is Globus Medical in the NASDAQ 100?

No, Globus Medical is not included in the NASDAQ 100 index

Is Globus Medical in the Dow Jones?

No, Globus Medical is not included in the Dow Jones index

When was Globus Medical's last earnings report?

Globus Medical's most recent earnings report was on Feb 20, 2025

When does Globus Medical report earnings?

The next expected earnings date for Globus Medical is May 7, 2025

Should I buy Globus Medical stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page